InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Pruzanski Mark, Director. Officer active across 2 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 21 filings have been published. Breakdown: 0 buy · 2 sells. Activity tracked since 30 April 2021. The latest transaction was filed on 8 November 2023 (U). Regulator: SEC (Form 4). The full history is free.
Declarations21 total
618,894 shares@ US$19.0088.5% of flowCommon StockSEC:0001104659-23-117094:0
6,138 shares@ US$17.216.5% of flowCommon StockSEC:0001104659-21-145908:0
6,138 shares@ US$17.2113.1% of flowCommon StockSEC:0001104659-21-145908
6,138 shares@ US$16.866.2% of flowCommon StockSEC:0001104659-21-132983:0
6,138 shares@ US$16.860.7% of flowCommon StockSEC:0001104659-21-132983
6,136 shares@ US$14.855.5% of flowCommon StockSEC:0001104659-21-122560:0
6,136 shares@ US$14.850.6% of flowCommon StockSEC:0001104659-21-122560
6,138 shares@ US$14.915.4% of flowCommon StockSEC:0001104659-21-112144:0
6,138 shares@ US$14.910.6% of flowCommon StockSEC:0001104659-21-112144
6,138 shares@ US$17.286.2% of flowCommon StockSEC:0001104659-21-099031:0
6,138 shares@ US$17.280.7% of flowCommon StockSEC:0001104659-21-099031
6,136 shares@ US$19.970.8% of flowCommon StockSEC:0001104659-21-088399
6,136 shares@ US$19.977.2% of flowCommon StockSEC:0001104659-21-088399:0
6,138 shares@ US$16.635.9% of flowCommon StockSEC:0001104659-21-075896:0
6,138 shares@ US$16.635.9% of flowCommon StockSEC:0001104659-21-075896
6,138 shares@ US$19.787.0% of flowCommon StockSEC:0001104659-21-061181
6,138 shares@ US$19.787.0% of flowCommon StockSEC:0001104659-21-061181:0
23,300 sharesCommon StockSEC:0001144204-16-081816:0
4,868 sharesCommon StockSEC:0001144204-16-074237:0
2,001 sharesCommon StockSEC:0001144204-16-074237:1
125 sharesCommon StockSEC:0001144204-16-074237:2
21 of 21 declarations
About Pruzanski Mark
Mark Pruzanski is an executive at INTERCEPT PHARMACEUTICALS, INC.
